Jagdish Prasad Meena
Overview
Explore the profile of Jagdish Prasad Meena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bansal S, Kumar R, Gupta A, Meena J, Seth R
Indian Pediatr
. 2025 Feb;
62(2):148-150.
PMID: 39912276
The management of high-risk neuroblastoma has dismal outcomes in low-and-middle-income countries (LMICs). There is limited data on post transplant outcomes of high-risk neuroblastoma from LMICs. We report the outcomes of...
2.
Gupta A, Ahmad A, Kakker D, Meena J, Majhi R, Jan A, et al.
Microrna
. 2025 Jan;
PMID: 39810535
Introduction: Micro ribonucleic acids (miRNAs) are small non-coding RNAs that modulate the expression of various genes. They have an important role in cancer pathogenesis. Differential expression of multiple miRNAs have...
3.
Chopra K, Gupta A, Meena J, Chakrabarty B, Sagar R, Pandey R, et al.
Indian J Pediatr
. 2025 Jan;
PMID: 39775716
Objectives: To determine the prevalence of psychiatric morbidities in survivors of pediatric acute lymphoblastic leukemia (ALL) and to identify any risk factors. Methods: Survivors of ALL, who had completed their...
4.
Sarangarajan S, Singh S, Gupta A, Meena J, Seth R
Indian J Pediatr
. 2025 Jan;
92(3):308.
PMID: 39745595
No abstract available.
5.
Das G, Setlur K, Jana M, Ramakrishnan L, Jain V, Meena J, et al.
Support Care Cancer
. 2024 Nov;
32(12):826.
PMID: 39592473
Purpose: Sarcopenic obesity, characterized by increased adiposity with low skeletal muscle mass, contributes to frailty and the development of chronic disease. Data on sarcopenic obesity in survivors of childhood acute...
6.
Grotra R, Karri P, Gupta A, Malik R, Gupta A, Meena J, et al.
Pediatr Transplant
. 2024 Nov;
28(8):e14891.
PMID: 39539152
Background: Inflammatory bowel diseases are complex chronic disorders with a relapsing-remitting course that affect the gut due to dysregulated immune response. The incidence of these disorders is increasing globally along...
7.
Gupta A, Meena J, Naranje P, Coshic P, Kanga U, Seth R
Indian Pediatr
. 2024 Jun;
61(6):564-570.
PMID: 38872290
Objective: To report the outcomes of pediatric patients who underwent allogeneic hematopoietic stem cell transplant (HSCT) in single rooms without high-efficiency particulate air (HEPA) filters, laminar air flow or positive...
8.
Chakraborty S, Gupta A, Gupta N, Meena J, Seth R, Kabra M
Indian J Pediatr
. 2024 Apr;
91(8):830-838.
PMID: 38639861
Storage disorders are a group of inborn errors of metabolism caused by the defective activity of lysosomal enzymes or transporters. All of these disorders have multisystem involvement with variable degrees...
9.
Riedmeier M, Antonini S, Brandalise S, Costa T, Daiggi C, de Figueiredo B, et al.
Eur J Endocrinol
. 2024 Mar;
190(4):G15-G24.
PMID: 38552173
Objective: Mitotane is an important cornerstone in the treatment of pediatric adrenal cortical tumors (pACC), but experience with the drug in the pediatric age group is still limited and current...
10.
Gupta A, Meena J, Seth R, Naranje P, Mohanty S, Coshic P
Blood Cell Ther
. 2024 Mar;
7(1):25-32.
PMID: 38486828
Autologous stem cell transplantation (ASCT) is the standard treatment for many high-risk solid tumors. Patients undergoing ASCT should be managed in a dedicated hematopoietic stem cell transplantation (HSCT) unit with...